4142.TW
Price:
$19.5
Market Cap:
$8.22B
Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is headquartered in Taichung, Taiwan.
Industry
Biotechnology
IPO Date
2012-05-03
Stock Exchange
TAI
Ticker
4142.TW
According to Adimmune Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -16.12. This represents a change of -64.13% compared to the average of -44.94 of the last 4 quarters.
The mean historical PE Ratio of Adimmune Corporation over the last ten years is 39.65. The current -16.12 PE Ratio has changed -4165.61% with respect to the historical average. Over the past ten years (40 quarters), 4142.TW's PE Ratio was at its highest in in the June 2022 quarter at 88.86. The PE Ratio was at its lowest in in the September 2018 quarter at -181.56.
Average
39.65
Median
-7.47
Minimum
-34.90
Maximum
445.31
Discovering the peaks and valleys of Adimmune Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.31%
Maximum Annual PE Ratio = 445.31
Minimum Annual Increase = -156.47%
Minimum Annual PE Ratio = -34.90
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -34.90 | 60.03% |
| 2023 | -21.81 | -141.72% |
| 2022 | 52.27 | -88.26% |
| 2021 | 445.31 | 2.31% |
| 2020 | 18.48 | -156.47% |
| 2019 | -32.73 | 352.10% |
| 2018 | -7.24 | 16.90% |
| 2017 | -6.19 | -31.05% |
| 2016 | -8.98 | 16.63% |
| 2015 | -7.70 | -22.74% |
The current PE Ratio of Adimmune Corporation (4142.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.48
5-year avg
91.87
10-year avg
39.65
Adimmune Corporation’s PE Ratio is greater than CHO Pharma, Inc. (-26.48), greater than TaiGen Biopharmaceuticals Holdings Limited (-45.97), less than Mycenax Biotech Inc. (-13.11), greater than Pharmosa Biopharm Inc. (-29.04), less than Acepodia, Inc. (-13.59), greater than AP Biosciences Inc (-34.52), less than OBI Pharma, Inc. (-3.22), greater than BioGend Therapeutics Co., Ltd. (-45.71), less than Sinphar Pharmaceutical Co.,Ltd. (16.77), less than PharmaEngine, Inc. (6.18),
| Company | PE Ratio | Market cap |
|---|---|---|
| -26.48 | $6.10B | |
| -45.97 | $8.61B | |
| -13.11 | $6.32B | |
| -29.04 | $7.00B | |
| -13.59 | $8.98B | |
| -34.52 | $13.62B | |
| -3.22 | $7.76B | |
| -45.71 | $4.74B | |
| 16.77 | $5.82B | |
| 6.18 | $10.34B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adimmune Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adimmune Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Adimmune Corporation's PE Ratio?
How is the PE Ratio calculated for Adimmune Corporation (4142.TW)?
What is the highest PE Ratio for Adimmune Corporation (4142.TW)?
What is the 3-year average PE Ratio for Adimmune Corporation (4142.TW)?
What is the 5-year average PE Ratio for Adimmune Corporation (4142.TW)?
How does the current PE Ratio for Adimmune Corporation (4142.TW) compare to its historical average?